Biomarker Discovery & Validation: Page 2

Biomarkers may predict stem cell transplant risks

By Elissa Wolfson

A biomarker for donor stem cell transplant risk may help doctors predict which patients will develop potentially deadly sinusoidal obstruction syndrome.

May 23, 2023

Biomarker predicts response to chemo-immunotherapy in lung cancer patients

By Nick Paul Taylor

Researchers see a correlation between CX3CR1 expression and outcomes in NSCLC patients treated with chemo-immunotherapy.

May 15, 2023

Hallmark Parkinson’s disease protein may aid early detection

By Elissa Wolfson

Identifying hallmark Parkinson’s disease misfolded protein deposits could aid early detection and pave the way for improved diagnosis and treatment.

April 12, 2023

Simple blood test can detect PTSD biomarkers

By Elissa Wolfson

People at risk or suffering from post-traumatic stress disorder show specific patterns in four biomarkers measurable with a simple blood test.

March 28, 2023

AriBio, Fujirebio partner on biomarker development for Alzheimer’s, other neurodegenerative disorders

By LabPulse.com staff writers

The agreement will provide Fujirebio access to clinical samples and data that have been collected in an ongoing phase III Alzheimer’s disease study being conducted by AriBio.

March 8, 2023

Protein expression biomarker may identify likely responders to potential breast cancer drug

By Nick Paul Taylor

In a study, researchers sought to understand the value of RANK and RANKL protein expression as a predictor of breast cancer outcomes and as a therapeutic target.

March 8, 2023

ApoB testing may reveal patients at risk of heart disease missed by cholesterol tests: study

By Nick Paul Taylor

In the study, investigators looked at electronic medical records for patients who had ApoB and standard lipid profiles tested within 90 days of each other from 2010 to early 2022.

March 6, 2023

Biocare Medical acquires Empire Genomics to expand molecular biomarker portfolio

By LabPulse.com staff writers

The acquisition of Empire Genomics will expand Biocare Medical’s molecular biomarker portfolio substantially.

November 22, 2022

Universal Diagnostics study assesses methylation biomarkers' role in early colorectal cancer

By LabPulse.com staff writers

The company will present the findings at the AACR Special Conference on Precisions, Prevention, Early Detection, and Interception of Cancer being held in Austin, TX, November 17-19.

November 17, 2022

Mainz Biomed initiates U.S. extension of colorectal cancer study to evaluate mRNA biomarkers

By LabPulse.com staff writers

Mainz Biomed announced an extension of its ColoFuture European study, which aims to evaluate the use of mRNA biomarkers for the early detection of colorectal cancer.

November 15, 2022

Akoya Biosciences launches panels for spatial biomarker discovery and validation

By LabPulse.com staff writers

The PhenoCode Signature Panels are a hybrid of the company’s legacy Codex and Opal assays, and, when combined with the PhenoImager platforms, enable spatial phenotyping workflow, Akoya said.

November 8, 2022

QMC Health, Lawson Health Research ink agreement for long-COVID blood biomarkers

By LabPulse.com staff writers

With blood biomarkers acquired in an agreement with Lawson Health Research Institute, QMC Health plans to develop a point-of-care rapid test using its QDX HPFIS technology.

November 1, 2022

Previous Page

Page 2 of 4

Next Page